Status:

TERMINATED

Effects of Alcohol and Mood on Attention

Lead Sponsor:

University of Alabama at Birmingham

Conditions:

Suicidal Ideas

Eligibility:

All Genders

21-65 years

Phase:

NA

Brief Summary

Acute use of alcohol is related to increased risk for suicide. However, our understanding of this problem is hindered by the lack of experimental tests of conditions underlying the alcohol use-suicide...

Detailed Description

This is a pilot study designed to explore the combined effects of acute use of alcohol, mood, and alcohol expectancies on attentional bias towards suicide. Community adults (n = 120) will be recruited...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • be between the ages of 21 and 65
  • have consumed an average of at least five or more (four or more for females) standard alcoholic drinks per occasion once over the past year
  • have self-administered a quantity of alcohol that is equal to or greater than the dose that will be administered in the lab on at least three occasions in the past year
  • be able to read and write in English fluently.
  • Exclusion criteria:
  • active psychosis, suicidal ideation/intent, or mania; currently receiving psychiatric treatment; have received psychiatric treatment in past year or currently experiencing significant psychiatric distress
  • in treatment or recovery from drug or alcohol use disorders or abstaining from alcohol
  • any suicide attempt history
  • pregnant/breast-feeding or immediate plans to become pregnant
  • any chronic health problems or medications that would preclude the use of alcohol
  • (to minimize adverse reactions to alcohol/inappropriate alcohol dose) \< 6 feet tall and over 230 lbs., or \> 6 feet tall and over 250 lbs.
  • color-blind or sight-impaired
  • knowing someone who has participated in this study.

Exclusion

    Key Trial Info

    Start Date :

    March 10 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 8 2023

    Estimated Enrollment :

    26 Patients enrolled

    Trial Details

    Trial ID

    NCT04276779

    Start Date

    March 10 2022

    End Date

    December 8 2023

    Last Update

    March 11 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Caitlin Clevenger

    Birmingham, Alabama, United States, 35233